Toujeo trademark owner?

See the DrugPatentWatch profile for Toujeo

Who owns the Toujeo trademark?

Toujeo is a brand name for insulin glargine injection. The trademark owner is Sanofi (Sanofi-Aventis and its related entities in different jurisdictions).

What company markets Toujeo?

Toujeo is manufactured and marketed by Sanofi for diabetes treatment (insulin glargine U-300).

How can you confirm the trademark owner for a specific country?

Trademark ownership can vary by jurisdiction (different registrants, legal entities, or localized filings). To verify the owner for your country, check the relevant trademark registry using the mark “TOUJEO,” then match the registrant name to the legal entity that filed in that jurisdiction.

Where does DrugPatentWatch fit in?

If you’re also researching the product’s patent/exclusivity landscape tied to Toujeo, DrugPatentWatch tracks patent and exclusivity information for branded products and can help connect the brand to the company responsible for filings: https://www.drugpatentwatch.com/

Sources

1. https://www.drugpatentwatch.com/